{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:41:33Z","timestamp":1762674093039,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TR60","GRK1949"],"award-info":[{"award-number":["TR60","GRK1949"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12977-016-0258-9","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T19:06:47Z","timestamp":1460142407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection"],"prefix":"10.1186","volume":"13","author":[{"given":"Torben","family":"Knuschke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Rotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wibke","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoriya","family":"Sokolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebke","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Sparwasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Dittmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Epple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Buer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid M.","family":"Westendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"issue":"9412","key":"258_CR1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0140-6736(04)15735-8","volume":"363","author":"C Hess","year":"2004","unstructured":"Hess C, Altfeld M, Thomas SY, et al. HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication. Lancet. 2004;363(9412):863\u20136.","journal-title":"Lancet"},{"issue":"12","key":"258_CR2","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1128\/JVI.79.12.7860-7867.2005","volume":"79","author":"T Boettler","year":"2005","unstructured":"Boettler T, Spangenberg HC, Neumann-Haefelin C, et al. T cells with a CD4+ CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol. 2005;79(12):7860\u20137.","journal-title":"J Virol"},{"issue":"2","key":"258_CR3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.gastro.2012.10.047","volume":"144","author":"B Seigel","year":"2013","unstructured":"Seigel B, Bengsch B, Lohmann V, Bartenschlager R, Blum HE, Thimme R. Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo. Gastroenterology. 2013;144(2):426\u201336.","journal-title":"Gastroenterology"},{"issue":"4","key":"258_CR4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ni1181","volume":"6","author":"Y Belkaid","year":"2005","unstructured":"Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol. 2005;6(4):353\u201360.","journal-title":"Nat Immunol"},{"issue":"6","key":"258_CR5","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1073\/pnas.1015148108","volume":"108","author":"KK Dietze","year":"2011","unstructured":"Dietze KK, Zelinskyy G, Gibbert K, et al. Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points. Proc Natl Acad Sci USA. 2011;108(6):2420\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"258_CR6","doi-asserted-by":"crossref","first-page":"e1000406","DOI":"10.1371\/journal.ppat.1000406","volume":"5","author":"G Zelinskyy","year":"2009","unstructured":"Zelinskyy G, Dietze K, Sparwasser T, Dittmer U. Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus. PLoS Pathog. 2009;5(8):e1000406.","journal-title":"PLoS Pathog"},{"issue":"14","key":"258_CR7","doi-asserted-by":"crossref","first-page":"8960","DOI":"10.1128\/JVI.79.14.8960-8968.2005","volume":"79","author":"EJ Wherry","year":"2005","unstructured":"Wherry EJ, Blattman JN, Ahmed R. Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination. J Virol. 2005;79(14):8960\u20138.","journal-title":"J Virol"},{"issue":"12","key":"258_CR8","doi-asserted-by":"crossref","first-page":"e1003798","DOI":"10.1371\/journal.ppat.1003798","volume":"9","author":"KK Dietze","year":"2013","unstructured":"Dietze KK, Zelinskyy G, Liu J, Kretzmer F, Schimmer S, Dittmer U. Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads. PLoS Pathog. 2013;9(12):e1003798.","journal-title":"PLoS Pathog"},{"issue":"15","key":"258_CR9","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1182\/blood-2009-03-208736","volume":"114","author":"G Zelinskyy","year":"2009","unstructured":"Zelinskyy G, Dietze KK, Husecken YP, et al. The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. Blood. 2009;114(15):3199\u2013207.","journal-title":"Blood"},{"issue":"166","key":"258_CR10","doi-asserted-by":"crossref","first-page":"166ra2","DOI":"10.1126\/scitranslmed.3004682","volume":"5","author":"F Garcia","year":"2013","unstructured":"Garcia F, Climent N, Guardo AC, et al. A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication. Sci Transl Med. 2013;5(166):166ra2.","journal-title":"Sci Transl Med"},{"issue":"9","key":"258_CR11","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/eji.201344433","volume":"44","author":"Y Levy","year":"2014","unstructured":"Levy Y, Thiebaut R, Montes M, et al. Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load. Eur J Immunol. 2014;44(9):2802\u201310.","journal-title":"Eur J Immunol"},{"issue":"7493","key":"258_CR12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature12978","volume":"507","author":"H Liu","year":"2014","unstructured":"Liu H, Moynihan KD, Zheng Y, et al. Structure-based programming of lymph-node targeting in molecular vaccines. Nature. 2014;507(7493):519\u201322.","journal-title":"Nature"},{"issue":"10","key":"258_CR13","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s11095-014-1419-y","volume":"31","author":"P Sahdev","year":"2014","unstructured":"Sahdev P, Ochyl LJ, Moon JJ. Biomaterials for nanoparticle vaccine delivery systems. Pharm Res. 2014;31(10):2563\u201382.","journal-title":"Pharm Res"},{"issue":"21","key":"258_CR14","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1016\/j.biomaterials.2010.03.067","volume":"31","author":"V Sokolova","year":"2010","unstructured":"Sokolova V, Knuschke T, Kovtun A, Buer J, Epple M, Westendorf AM. The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation. Biomaterials. 2010;31(21):5627\u201333.","journal-title":"Biomaterials"},{"issue":"7","key":"258_CR15","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.1016\/j.actbio.2013.02.034","volume":"9","author":"V Sokolova","year":"2013","unstructured":"Sokolova V, Kozlova D, Knuschke T, Buer J, Westendorf AM, Epple M. Mechanism of the uptake of cationic and anionic calcium phosphate nanoparticles by cells. Acta Biomater. 2013;9(7):7527\u201335.","journal-title":"Acta Biomater"},{"issue":"12","key":"258_CR16","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.4049\/jimmunol.1202654","volume":"190","author":"T Knuschke","year":"2013","unstructured":"Knuschke T, Sokolova V, Rotan O, et al. Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection. J Immunol. 2013;190(12):6221\u20139.","journal-title":"J Immunol"},{"issue":"8","key":"258_CR17","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.nano.2014.06.014","volume":"10","author":"T Knuschke","year":"2014","unstructured":"Knuschke T, Bayer W, Rotan O, et al. Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protective immunity during acute and chronic retroviral infection. Nanomedicine. 2014;10(8):1787\u201398.","journal-title":"Nanomedicine"},{"key":"258_CR18","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2741\/2167","volume":"12","author":"KJ Hasenkrug","year":"2007","unstructured":"Hasenkrug KJ, Dittmer U. Immune control and prevention of chronic Friend retrovirus infection. Front Biosci. 2007;12:1544\u201351.","journal-title":"Front Biosci"},{"issue":"6","key":"258_CR19","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.4049\/jimmunol.1400649","volume":"193","author":"JJ Joedicke","year":"2014","unstructured":"Joedicke JJ, Myers L, Carmody AB, et al. Activated CD8\u00a0+\u00a0T cells induce expansion of Vbeta5+ regulatory T cells via TNFR2 signaling. J Immunol. 2014;193(6):2952\u201360.","journal-title":"J Immunol"},{"issue":"1","key":"258_CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2012-07-409755","volume":"121","author":"MF Chevalier","year":"2013","unstructured":"Chevalier MF, Weiss L. The split personality of regulatory T cells in HIV infection. Blood. 2013;121(1):29\u201337.","journal-title":"Blood"},{"issue":"4","key":"258_CR21","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1128\/JVI.01840-09","volume":"84","author":"W Bayer","year":"2010","unstructured":"Bayer W, Tenbusch M, Lietz R, et al. Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection. J Virol. 2010;84(4):1967\u201376.","journal-title":"J Virol"},{"issue":"2","key":"258_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/5550","volume":"5","author":"U Dittmer","year":"1999","unstructured":"Dittmer U, Brooks DM, Hasenkrug KJ. Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection. Nat Med. 1999;5(2):189\u201393.","journal-title":"Nat Med"},{"issue":"12","key":"258_CR23","doi-asserted-by":"crossref","first-page":"e82528","DOI":"10.1371\/journal.pone.0082528","volume":"8","author":"I Ohs","year":"2013","unstructured":"Ohs I, Windmann S, Wildner O, Dittmer U, Bayer W. Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection. PLoS One. 2013;8(12):e82528.","journal-title":"PLoS One"},{"issue":"24","key":"258_CR24","doi-asserted-by":"crossref","first-page":"12202","DOI":"10.1073\/pnas.89.24.12202","volume":"89","author":"KS Ruan","year":"1992","unstructured":"Ruan KS, Lilly F. Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus. Proc Natl Acad Sci USA. 1992;89(24):12202\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"258_CR25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1742-4690-10-109","volume":"10","author":"G Zelinskyy","year":"2013","unstructured":"Zelinskyy G, Werner T, Dittmer U. Natural regulatory T cells inhibit production of cytotoxic molecules in CD8(+) T cells during low-level Friend retrovirus infection. Retrovirology. 2013;10:109.","journal-title":"Retrovirology"},{"issue":"1","key":"258_CR26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.20061852","volume":"204","author":"K Lahl","year":"2007","unstructured":"Lahl K, Loddenkemper C, Drouin C, et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med. 2007;204(1):57\u201363.","journal-title":"J Exp Med"},{"issue":"4","key":"258_CR27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1158\/1078-0432.CCR-10-2227","volume":"17","author":"IJ Vries de","year":"2011","unstructured":"de Vries IJ, Castelli C, Huygens C, et al. Frequency of circulating Tregs with demethylated FOXP3 intron 1 in melanoma patients receiving tumor vaccines and potentially Treg-depleting agents. Clin Cancer Res. 2011;17(4):841\u20138.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"258_CR28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tips.2014.02.003","volume":"35","author":"J Bayry","year":"2014","unstructured":"Bayry J, Tartour E, Tough DF. Targeting CCR4 as an emerging strategy for cancer therapy and vaccines. Trends Pharmacol Sci. 2014;35(4):163\u20135.","journal-title":"Trends Pharmacol Sci"},{"issue":"29","key":"258_CR29","doi-asserted-by":"crossref","first-page":"10221","DOI":"10.1073\/pnas.0803453105","volume":"105","author":"J Bayry","year":"2008","unstructured":"Bayry J, Tchilian EZ, Davies MN, et al. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination. Proc Natl Acad Sci USA. 2008;105(29):10221\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6193","key":"258_CR30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1255512","volume":"345","author":"DH Barouch","year":"2014","unstructured":"Barouch DH, Deeks SG. Immunologic strategies for HIV-1 remission and eradication. Science. 2014;345(6193):169\u201374.","journal-title":"Science"},{"issue":"3","key":"258_CR31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/cmi.2010.20","volume":"7","author":"YY Wan","year":"2010","unstructured":"Wan YY. Regulatory T cells: immune suppression and beyond. Cell Mol Immunol. 2010;7(3):204\u201310.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"258_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","volume":"6","author":"W Zou","year":"2006","unstructured":"Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006;6(4):295\u2013307.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"258_CR33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JVI.75.1.52-60.2001","volume":"75","author":"M Iwashiro","year":"2001","unstructured":"Iwashiro M, Peterson K, Messer RJ, Stromnes IM, Hasenkrug KJ. CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection. J Virol. 2001;75(1):52\u201360.","journal-title":"J Virol"},{"issue":"10","key":"258_CR34","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/eji.200636059","volume":"36","author":"G Zelinskyy","year":"2006","unstructured":"Zelinskyy G, Kraft AR, Schimmer S, Arndt T, Dittmer U. Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection. Eur J Immunol. 2006;36(10):2658\u201370.","journal-title":"Eur J Immunol"},{"issue":"12","key":"258_CR35","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1182\/blood-2006-05-021576","volume":"108","author":"J Nilsson","year":"2006","unstructured":"Nilsson J, Boasso A, Velilla PA, et al. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV\/AIDS. Blood. 2006;108(12):3808\u201317.","journal-title":"Blood"},{"issue":"1","key":"258_CR36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/vim.2009.0061","volume":"23","author":"XP Nan","year":"2010","unstructured":"Nan XP, Zhang Y, Yu HT, et al. Circulating CD4+ CD25 high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection. Viral Immunol. 2010;23(1):63\u201370.","journal-title":"Viral Immunol"},{"issue":"12","key":"258_CR37","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","volume":"107","author":"MR Betts","year":"2006","unstructured":"Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107(12):4781\u20139.","journal-title":"Blood"},{"key":"258_CR38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-387827-4.00003-6","volume":"112","author":"RM Maizels","year":"2011","unstructured":"Maizels RM, Smith KA. Regulatory T cells in infection. Adv Immunol. 2011;112:73\u2013136.","journal-title":"Adv Immunol"},{"issue":"6","key":"258_CR39","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1084\/jem.20030171","volume":"198","author":"S Suvas","year":"2003","unstructured":"Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT. CD4+ CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med. 2003;198(6):889\u2013901.","journal-title":"J Exp Med"},{"issue":"10","key":"258_CR40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/icb.2014.62","volume":"92","author":"NH Jost","year":"2014","unstructured":"Jost NH, Abel S, Hutzler M, et al. Regulatory T cells and T-cell-derived IL-10 interfere with effective anti-cytomegalovirus immune response. Immunol Cell Biol. 2014;92(10):860\u201371.","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"258_CR41","doi-asserted-by":"crossref","first-page":"e9852","DOI":"10.1371\/journal.pone.0009852","volume":"5","author":"BJ Macatangay","year":"2010","unstructured":"Macatangay BJ, Szajnik ME, Whiteside TL, Riddler SA, Rinaldo CR. Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART. PLoS One. 2010;5(3):e9852.","journal-title":"PLoS One"},{"issue":"5","key":"258_CR42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/COH.0000000000000087","volume":"9","author":"N Seddiki","year":"2014","unstructured":"Seddiki N, Brezar V, Draenert R. Cell exhaustion in HIV-1 infection: role of suppressor cells. Curr Opin HIV AIDS. 2014;9(5):452\u20138.","journal-title":"Curr Opin HIV AIDS"},{"issue":"7","key":"258_CR43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8(7):523\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"258_CR44","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.immuni.2008.10.010","volume":"29","author":"SA Migueles","year":"2008","unstructured":"Migueles SA, Osborne CM, Royce C, et al. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity. 2008;29(6):1009\u201321.","journal-title":"Immunity"},{"issue":"21","key":"258_CR45","doi-asserted-by":"crossref","first-page":"11881","DOI":"10.1128\/JVI.01554-07","volume":"81","author":"G Zelinskyy","year":"2007","unstructured":"Zelinskyy G, Balkow S, Schimmer S, Werner T, Simon MM, Dittmer U. The level of friend retrovirus replication determines the cytolytic pathway of CD8+ T-cell-mediated pathogen control. J Virol. 2007;81(21):11881\u201390.","journal-title":"J Virol"},{"issue":"6","key":"258_CR46","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1086\/517414","volume":"177","author":"U Dittmer","year":"1998","unstructured":"Dittmer U, Hunsmann G. Antiviral CD4 cell response in simian immunodeficiency virus-infected macaques. J Infect Dis. 1998;177(6):1771\u20132.","journal-title":"J Infect Dis"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-016-0258-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T06:23:11Z","timestamp":1498285391000},"score":1,"resource":{"primary":{"URL":"http:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-016-0258-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,14]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["258"],"URL":"https:\/\/doi.org\/10.1186\/s12977-016-0258-9","relation":{},"ISSN":["1742-4690"],"issn-type":[{"type":"electronic","value":"1742-4690"}],"subject":[],"published":{"date-parts":[[2016,4,14]]},"article-number":"24"}}